Skip to main content
Fig. 3 | BMC Cancer

Fig. 3

From: Peripheral blood lymphocytes differentiation patterns in responses / outcomes to immune checkpoint blockade therapies in non-small cell lung cancer: a retrospective study

Fig. 3

PFS and OS curves. A-J and M Kaplan–Meier curves for PFS or OS. K and L PFS and OS Hazard ratio and 95%CI show in the Forest plot, respectively. P Values were calculated by log-rank statistics. ECOG PS, Eastern Cooperative Oncology Group performance status; CA125, carbohydrate antigen 125. PFS, progression-free survival; OS, Overall survival

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us